je.st
news
Home
› Genedata Biologics 4.0 Enables Large-Scale Design, Synthesis, And Testing Of Bispecific Antibodies
Genedata Biologics 4.0 Enables Large-Scale Design, Synthesis, And Testing Of Bispecific Antibodies
2014-04-02 06:26:51| drugdiscoveryonline News Articles
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the release of Genedata Biologics™ 4.0, the latest version of its enterprise workflow support and data management solution for biologics R&D
Tags: design
testing
enables
synthesis
Category:Biotechnology and Pharmaceuticals